RAAS Nutritionals, LLC

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

1 in Phase 3

Quick facts

Phase 3 pipeline

Ceftriaxone/ Clarithromycin · Infectious Disease
This combination uses a third-generation cephalosporin antibiotic and a macrolide antibiotic to inhibit bacterial cell wall synthesis and protein synthesis, respectively, providing broad-spectrum antimicrobial coverage.

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

RAAS Nutritionals, LLC portfolio CI brief
RAAS Nutritionals, LLC pipeline updates RSS

Frequently asked questions about RAAS Nutritionals, LLC

What is RAAS Nutritionals, LLC's pipeline?

RAAS Nutritionals, LLC has 1 drugs in Phase 3, 0 in Phase 2, 0 in Phase 1. Late-stage candidates include Ceftriaxone/ Clarithromycin.

Sector hub: All tracked pharma companies